查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1864177

输液袋市场按产品类型、应用、最终用户、分销管道、材质和销售划分－2025-2032年全球预测

Infusion Bags Market by Product Type, Application, End User, Distribution Channel, Material, Capacity - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，输液袋市场规模将达到 97.2 亿美元，复合年增长率为 7.09%。

关键市场统计数据
基准年 2024 56.2亿美元
预计年份：2025年 60.1亿美元
预测年份 2032 97.2亿美元
复合年增长率 (%) 7.09%

本文策略性地介绍了临床应用、材料创新、监管重点和供应链韧性等方面的变化如何重塑输液袋产业的优先事项。

输液袋产业处于临床需求、材料科学、法律规范以及不断变化的医疗路径的交汇点。对门诊和家庭输液的日益重视，以及对聚合物塑化剂和灭菌方法的严格审查，正迫使製造商和采购商重新评估产品设计、采购和临床工作流程。同时，医疗机构也更加重视易用性、降低污染风险和供应链可靠性，这使得即用型解决方案和大容量配方在特定治疗应用中的重要性日益凸显。

重新设计的材料、即用型临床工作流程和数数位化供应链管理如何从根本上重塑输液袋的生产和分销？

由于材料、临床工作流程和供应链结构同时面临压力，输液袋产业格局正经历变革性变化。在材料方面，监管机构对邻苯二甲酸酯和塑化剂迁移问题的日益关注，加速了从传统的聚氯乙烯（PVC）基体係向乙烯-醋酸乙烯酯共聚物（EVA）和聚烯）等替代材料的过渡。这促使企业开展材料重新设计专案并重新审视供应商关係。这种材料转型也与永续性努力相辅相成，製造商正在寻求低排放的生产方式，减少废弃物对环境的影响，并日益将生命週期概念融入设计和采购决策中。

对2025年美国实施关税及其后续策略转向国内生产、供应商多元化和库存弹性所带来的业务影响评估

主要经济体的政策变化和贸易行动会迅速波及医疗设备供应链。 2025年美国关税调整为输液袋生态系统带来了独特的营运压力。美国对进口原料聚合物、组件和成品输液袋征收关税，导致成本增加，迫使采购团队立即重新评估其供应商组合和服务交付成本。医疗采购部门的应对措施包括重新平衡库存、与值得信赖的供应商谈判长期合同，并在可能的情况下探索国内采购替代方案。这些倡议强化了对供应商灵活性和在不影响合规性的前提下扩大生产规模能力的重视。

基于深度细分的洞察，将产品销售、临床应用、终端用户环境、通路、材料选择和产能等级与营运优先事项连结起来。

要深入了解市场细分，需要将产品属性与临床应用案例紧密结合。根据产品类型，市场参与企业应考虑辅料、大容量和即用型 (RTU) 等规格。在大容量类别中，100-250 mL、250-500 mL、50-100 mL 和 >500 mL 这几个细分市场对生产工具、标籤检视复杂性和临床应用标准有显着影响。产品设计选择会影响灭菌方法和低温运输管理，因此，设计模组化平台以适应多种容量等级的製造商将能够同时实现营运效率和广泛的临床适用性。

美洲、欧洲、中东和非洲以及亚太地区的区域竞争和监管趋势将影响商业性参与策略和供应链设计。

区域趋势影响输液袋产业的竞争优势和监管负担。在美洲，大规模综合医疗保健系统和医院采购网络的集中分布带来了规模经济效益，但也要求严格遵守监管规定并保持成本透明。服务该地区的製造商必须平衡国内生产能力和全球采购选择，并受益于与医院药房部门的密切合作，以协助产品检验和处方集目录。

领先的製造商和供应商如何将材料创新、製造灵活性、严格的监管要求和附加价值服务相结合，以确保在输液袋领域获得竞争优势

输液袋生态系统中的主要企业正在采取多项协同策略，以应对材料转型、临床实践变化和供应链波动带来的多重压力。许多生产商正在加速研发，以验证非PVC配方，投资建造替代聚合物的试验生产线，并制定完善的生物相容性测试通讯协定，以满足日益严格的监管要求。这种以产品为中心的创新通常与对柔性製造平台和自动化焊接填充系统的营运投资相结合，从而在确保无菌性的同时，实现快速的产品换代。

为增强供应链韧性、加快向检验材料的过渡以及扩大临床整合的即用型解决方案，提供切实可行的策略和营运建议。

产业领导者应采取多管齐下的策略，将当前的挑战转化为可持续的竞争优势。首先，应优先考虑检验淘汰高风险塑化剂，并投入资源进行材料合格和过渡性研究，以证明其与关键治疗药物和灭菌方法的兼容性。这将有助于减少监管阻力，并确保其产品系列能够适应未来发展。同时，也应投资建置灵活的生产基础设施，使其能够满足多种产量等级的需求，并可快速改造生产线，以适应即用型产品，从而在不影响合规性的前提下，迅速响应不断变化的临床需求。

结合关键相关利益者访谈、技术检验和迭代三角测量等稳健的混合调查方法，得出可操作的供应和产品洞察。

本报告的分析基础结合了结构化的初步研究、严谨的二手研究以及跨学科综合分析。初步研究包括对医院和门诊医疗系统的采购主管、製造商的品质和法规专家以及灭菌和物流供应商的营运经理进行有针对性的访谈，以了解实际操作中的限制因素和决策标准。这些定性见解辅以对材料生物相容性文献、法规指导文件以及输液给药临床最佳实践通讯协定的技术审查，以确保符合安全性和性能要求。

对材料创新、製造弹性、法规遵循和供应链韧性的全面分析，将决定输液袋生态系统中的竞争成败。

输液袋产业正处于一个转折点，材料科学、不断发展的临床工作流程和政策选择相互交织，重新定义供应商和买家的行为。那些积极投资于检验的非PVC替代品、实现弹性製造自动化以及整合即用型输液袋临床支援服务的公司，将更有能力应对医疗服务中安全性和效率的双重挑战。同时，采购机构和医疗服务提供者必须优先考虑透过采购多元化和在地化生产能力来增强供应韧性，尤其是在贸易政策波动可能加剧投入成本压力的情况下。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 扩大内建物联网感测器的智慧输液袋的使用范围，以实现即时监测并提高输液准确性。
  • 为了最大限度地降低医院环境中的污染风险，对一次性输液袋的需求正在增加。
  • 扩大使用由环保材料製成且可回收性较高的柔性聚合物输液袋。
  • 在输液袋中加入抗菌和防污涂层，以降低加护治疗的感染率
  • 开发一种可客製化的输液袋平台，实现针对特定患者的药物剂量和配製。
  • 监管机构越来越重视输液袋可追溯性的品质标准和序列化合规性。
  • 肿瘤科和加护治疗领域对多腔输液袋的需求日益增长，这种输液袋能够稳定地配製敏感的生物製药。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的输液袋市场

  • 添加剂
  • 大容量
    • 100至250毫升
    • 250至500毫升
    • 50至100毫升
    • 超过500毫升
  • 即用型

第九章 按应用分類的输液袋市场

  • 输血
  • 化疗
  • 水疗法
  • 静脉营养

第十章 按终端用户分類的输液袋市场

  • 门诊手术中心
  • 诊所
  • 居家医疗
  • 医院

第十一章 按分销管道分類的输液袋市场

  • 直销
  • 医院药房
  • 网路药房
  • 零售药房

第十二章 依材质分類的输液袋市场

  • 乙烯-醋酸乙烯酯
  • 聚烯
  • PVC

第十三章 输液袋市场（以销量计）

  • 100至250毫升
  • 250至500毫升
  • 50至100毫升
  • 500毫升或更多

第十四章 输液袋市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 输液袋市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国输液袋市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • Terumo Corporation
    • Becton, Dickinson and Company
    • Pfizer Inc.
    • ICU Medical, Inc.
    • Nipro Corporation
    • Smiths Group plc
    • Hospira, Inc.
Product Code: MRR-0575DFF1B218

The Infusion Bags Market is projected to grow by USD 9.72 billion at a CAGR of 7.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.62 billion
Estimated Year [2025] USD 6.01 billion
Forecast Year [2032] USD 9.72 billion
CAGR (%) 7.09%

A strategic introduction to how clinical delivery shifts, materials innovation, regulatory emphasis, and supply resilience are reshaping infusion bag industry priorities

The infusion bag sector sits at the intersection of clinical need, materials science, regulatory oversight, and shifting care pathways. Increasing emphasis on ambulatory and home-based infusion, combined with heightened scrutiny of polymer plasticizers and sterilization practices, has driven manufacturers and purchasers to re-evaluate product design, sourcing, and clinical workflows. Simultaneously, healthcare providers are prioritizing ease of use, contamination risk reduction, and supply-chain reliability, which elevates the relevance of ready-to-use solutions and larger-volume formulations for specific therapeutic uses.

Manufacturers are responding through incremental innovation in materials and form factors, operational investments to increase production flexibility, and closer collaboration with healthcare systems to streamline product adoption. Regulatory agencies have emphasized patient safety and material biocompatibility, prompting accelerated reformulations and third-party testing regimes. As clinical delivery shifts toward outpatient infusion suites, ambulatory surgical centers, and at-home therapy, product developers and distributors must adapt packaging, labeling, and support services to match evolving point-of-care requirements.

This introduction frames the major vectors influencing supplier strategy and buyer behavior: patient-centric care models, sustainability and chemical safety concerns, the drive toward pre-filled and ready-to-use offerings, and the imperative to secure resilient, compliant supply chains that can support both hospital and home infusion needs. The remainder of this analysis explores how those vectors translate into operational priorities and commercial choices for stakeholders across the ecosystem.

How materials reformulation, ready-to-use clinical workflows, and digitalized supply-chain controls are driving a fundamental reconfiguration of infusion bag manufacturing and distribution

The infusion bag landscape is undergoing transformative shifts driven by simultaneous pressures on materials, clinical workflow, and supply-chain architecture. In materials, regulatory attention to phthalates and plasticizer migration has accelerated the transition from traditional polyvinyl chloride-based systems toward alternatives such as ethylene vinyl acetate and polyolefin, prompting reformulation programs and changes in supplier relationships. This materials transition intersects with sustainability ambitions, where manufacturers seek lower-emission production pathways and reduced end-of-life impact, progressively integrating life-cycle thinking into design and procurement decisions.

Clinically, the move toward ready-to-use formats aligns with efficiency and safety goals; pre-filled and single-use systems reduce preparation time, lower contamination risk, and support standardized dosing in high-volume settings. At the same time, demand for large-volume infusions in specific therapeutic areas, including hydration, parenteral nutrition, and certain chemotherapy regimens, persists and requires continued specialization across volume classes. Distribution dynamics evolve in response: hospital pharmacies and direct sales channels remain critical for acute care, while online and retail pharmacy channels grow in importance for outpatient and home infusion services.

Operationally, companies are investing in manufacturing automation, quality system harmonization, and digital traceability to improve batch transparency and expedite regulatory submissions. The cumulative effect is a market that prizes adaptable production, validated material alternatives, and integrated services that span product, logistics, and point-of-care support, positioning suppliers who can execute on these fronts to meet changing provider priorities.

Evaluating the operational consequences of U.S. tariff measures introduced in 2025 and the subsequent strategic pivot toward domestic production, supplier diversification, and inventory resilience

Policy shifts and trade measures implemented by major economies can quickly reverberate through medical-device supply chains, and the United States tariff adjustments in 2025 introduced specific operational pressures for the infusion bag ecosystem. Tariff-induced cost increases on imported raw polymers, components, or finished bags created an immediate need for procurement teams to reassess supplier portfolios and cost-to-serve calculations. Healthcare purchasers responded by rebalancing inventories, negotiating longer-term commitments with trusted suppliers, and exploring domestic sourcing alternatives where feasible. These dynamics placed a premium on supplier agility and the capacity to scale production without compromising compliance.

Beyond direct input-cost effects, tariffs influenced strategic supplier selection and the geography of value-added activities. Some manufacturers accelerated efforts to localize critical production steps such as film extrusion, welding, and terminal sterilization to reduce exposure to cross-border policy volatility. Others pursued vertical partnerships or joint ventures to secure access to key polymer chemistries and to share the capital burden of establishing localized capabilities. In parallel, distributors adapted pricing and contract structures to mitigate immediate margin pressure while preserving supply continuity for hospitals and home-care networks.

Clinically, procurement teams in high-volume acute-care settings prioritized continuity over short-term price wins, while outpatient and home-health providers sought cost-stable offerings that preserved adherence to therapy. The tariff environment therefore reinforced a strategic shift toward supply resilience, inventory optimization, and supplier diversification, underscoring the importance of robust scenario planning and closer alignment between procurement, regulatory, and clinical stakeholders to maintain uninterrupted patient care.

Deep segmentation-driven insights that map product volumes, clinical applications, end-user settings, distribution routes, material choices, and capacity classes to operational priorities

Segmentation insight requires precise alignment between product features and clinical use cases. Based on product type, market participants must account for Additive, Large Volume, and Ready-To-Use formats; within the Large Volume cohort, the distinctions across 100 To 250 Ml, 250 To 500 Ml, 50 To 100 Ml, and Above 500 Ml materially affect production tooling, labeling complexity, and clinical adoption criteria. Product design choices influence sterilization pathways and cold-chain handling, and manufacturers that design modular platforms capable of handling multiple volume classes achieve both operational efficiency and broader clinical applicability.

Clinical applications drive demand profiles and performance requirements. Based on application, studies commonly segment use across Blood Transfusion, Chemotherapy, Hydration Therapy, and Parenteral Nutrition; each of these applications imposes unique regulatory scrutiny, compatibility testing needs, and labeling expectations. For example, blood transfusion systems require specific material compatibility and traceability controls, while chemotherapy bags demand enhanced dosing accuracy and safety features to protect clinicians and patients during preparation and administration.

End-user context determines service and distribution requirements. Based on end user, the buyer universe spans Ambulatory Surgical Centers, Clinics, Home Healthcare, and Hospitals, and each setting has distinct procurement cycles, storage capacity, and clinical staff competencies. Distribution choices mediate how products reach these end users. Based on distribution channel, suppliers work through Direct Sales, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies to meet differing procurement cadences and regulatory constraints. Material selection underpins overall product performance. Based on material, designs commonly deploy Ethylene Vinyl Acetate, Polyolefin, and PVC, and each chemistry presents trade-offs among flexibility, leachables profile, and manufacturing cost. Finally, capacity considerations often duplicate volume segmentation. Based on capacity, the production and inventory strategy reflects 100 To 250 Ml, 250 To 500 Ml, 50 To 100 Ml, and Above 500 Ml classes, and aligning capacity to clinical demand reduces waste and supports timely delivery. Integrated segmentation analysis therefore requires mapping product specs to application needs, end-user constraints, distribution routes, material science, and capacity planning to create commercially viable offerings.

Regional competitive and regulatory dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine commercial entry strategies and supply-chain design

Regional dynamics shape competitive advantage and regulatory burden across the infusion bag industry. In the Americas, large integrated healthcare systems and a concentration of hospital procurement networks create scale opportunities but also demand rigorous regulatory compliance and cost transparency. Manufacturers serving this region must balance domestic production capabilities with global sourcing options, and they benefit from close collaboration with hospital pharmacy departments to support product validation and formulary inclusion.

The Europe, Middle East & Africa region presents a heterogeneous regulatory and reimbursement landscape with advanced clinical adoption in some markets and capacity constraints in others. Suppliers operating across this territory must navigate varying regulatory regimes for materials and sterilization validation, while also designing distribution and training programs that accommodate diverse clinical workflows. Strategic partnerships with regional distributors and local sterilization or packaging providers can accelerate market entry and reduce logistical complexity.

Asia-Pacific features strong manufacturing capabilities, rapidly growing healthcare infrastructure, and high demand for cost-effective product variants. Suppliers looking to scale in this region often invest in localized manufacturing or contract production to address tariff exposure and to meet regional procurement preferences. Across all regions, cross-border regulatory harmonization efforts and international quality standards remain central to enabling multi-market supply, and successful companies tailor commercial models to the procurement and clinical norms of each geographic area while maintaining consistent quality and traceability.

How leading manufacturers and suppliers are aligning material innovation, manufacturing agility, regulatory rigor, and value-added services to secure competitive advantage in infusion bags

Key companies across the infusion bag ecosystem are responding to the combined pressures of material transition, clinical change, and supply-chain volatility by pursuing several coordinated strategies. Many producers are accelerating R&D to qualify non-PVC formulations, investing in pilot lines for alternative polymers and creating robust biocompatibility testing protocols to meet heightened regulatory scrutiny. This product-centric innovation often pairs with operational investments in flexible manufacturing platforms and automated welding and filling systems that allow rapid SKU changeover while maintaining sterility assurance.

Strategic partnerships and manufacturing alliances have become common approaches to share the cost and timeline of capacity expansion, gain access to specialized extrusion or sterilization capabilities, and secure regional presence. Companies are also differentiating through service layers-providing pharmacy training modules, clinical workflow integration tools for Ready-To-Use products, and data-driven lot tracking to support recalls or complaint investigations. On the commercial front, select suppliers are optimizing channel strategies by strengthening direct-sales relationships with large hospital systems while expanding distribution agreements for outpatient and home-care segments through retail and online pharmacy channels.

Quality and regulatory performance remain a primary competitive lever. Leading organizations demonstrate investment in comprehensive quality management systems, third-party testing, and regulatory engagement to accelerate product acceptance. Those that combine material science leadership with supply-chain resilience and clinical support services are better positioned to capture procurement attention and sustain long-term contracts with major care providers.

Actionable strategic and operational recommendations to fortify supply resilience, accelerate validated material transitions, and expand clinically integrated ready-to-use solutions

Industry leaders should adopt a multi-dimensional strategy to convert current disruption into durable advantage. First, prioritize validated transitions away from high-risk plasticizers by allocating resources to material qualification and bridging studies that document compatibility with key therapeutic agents and sterilization methods. This will reduce regulatory friction and future-proof product portfolios. Concurrently, invest in flexible manufacturing infrastructure that supports multiple volume classes and quick retooling for Ready-To-Use formats, enabling rapid response to shifting clinical demand without sacrificing compliance.

Second, strengthen supply-chain resilience by diversifying suppliers across geographies and by developing near-shore or local manufacturing partnerships for critical process steps such as film extrusion and terminal sterilization. Integrate scenario planning and stress-testing into procurement processes so that tariff shock or logistics disruptions trigger pre-defined sourcing responses rather than ad hoc decisions. Third, enhance value propositions through service integration: design training programs for hospital pharmacy staff, provide validated protocols for at-home infusion, and deploy digital traceability solutions to simplify lot-level investigations and recall response.

Fourth, engage proactively with regulators and healthcare purchasers to shape practical standards for alternative materials and Ready-To-Use products. Early collaboration reduces adoption friction and shortens time-to-formulary inclusion. Finally, embed sustainability metrics into product development and procurement decisions to meet growing institutional ESG expectations, including lifecycle assessments, recyclability initiatives where feasible, and reduced energy intensity in production. By coordinating these actions across R&D, operations, procurement, and commercial teams, industry leaders can both mitigate near-term volatility and build differentiated, durable offerings.

A robust mixed-methods research methodology combining primary stakeholder interviews, technical validation, and iterative triangulation to produce actionable supply and product insights

The analysis underpinning this report combined structured primary research with rigorous secondary validation and cross-functional synthesis. Primary inputs included targeted interviews with procurement leaders in hospitals and outpatient systems, quality and regulatory professionals within manufacturing firms, and operational managers from sterilization and logistics providers to capture real-world constraints and decision criteria. These qualitative insights were complemented by technical reviews of material biocompatibility literature, regulatory guidance documents, and clinical best-practice protocols for infusion administration to ensure alignment with safety and performance expectations.

Secondary research incorporated public regulatory filings, standards documentation, and industry publications to triangulate material chemistry trends and production technologies. Where appropriate, manufacturing capacity and process descriptions were validated through supplier-produced technical white papers and equipment vendor specifications. Data from distribution channel studies and hospital procurement cycle analyses informed the commercial model assumptions and scenario planning exercises used to evaluate resilience strategies.

The methodology emphasized iterative validation, where preliminary findings were tested in follow-up interviews and refined to reflect operational realities and regional regulatory nuances. All analytical steps included traceability to source materials and, where inference was necessary, transparent assumptions and sensitivity checks to ensure robustness. This approach balances qualitative depth with technical validation to produce recommendations that are actionable for procurement, regulatory, and commercial teams.

Concluding synthesis of how material innovation, manufacturing flexibility, regulatory engagement, and supply resilience will determine competitive success in the infusion bag ecosystem

The infusion bag sector is at a pivotal moment where material science, clinical workflow evolution, and policy choices converge to redefine supplier and purchaser behavior. Companies that proactively invest in validated non-PVC alternatives, automate flexible manufacturing capabilities, and integrate clinical support services for Ready-To-Use formats will be better positioned to meet the twin imperatives of safety and efficiency in care delivery. At the same time, procurement organizations and providers must prioritize supply resilience through diversified sourcing and localized capacity, particularly in the face of trade policy volatility that can amplify input-cost pressures.

Regulatory alignment and early stakeholder engagement will accelerate adoption by reducing validation friction and ensuring that new materials or formats meet clinical safety expectations. Meanwhile, sustainable production practices and lifecycle accountability are becoming differentiators in procurement decisions, influencing long-term partner selection. Ultimately, the organizations that combine technical rigor, operational adaptability, and commercial service depth will capture the greatest commercial opportunities while supporting uninterrupted, high-quality patient care across hospitals, ambulatory centers, and the expanding home-infusion setting.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of smart infusion bags with integrated IoT sensors for real-time monitoring and dosage accuracy
  • 5.2. Rising demand for single-use infusion bags to minimize contamination risks in hospital settings
  • 5.3. Expansion of flexible polymer-based infusion bags with eco-friendly materials and improved recyclability
  • 5.4. Integration of antimicrobial and anti-fouling coatings on infusion bags to reduce infection rates in critical care
  • 5.5. Development of customizable infusion bag platforms enabling patient-specific drug dosing and compounding
  • 5.6. Increasing regulatory focus on quality standards and serialization compliance for infusion bag traceability
  • 5.7. Surge in demand for multichamber infusion bags for stable co-formulation of sensitive biologics in oncology and critical care

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Infusion Bags Market, by Product Type

  • 8.1. Additive
  • 8.2. Large Volume
    • 8.2.1. 100 To 250 Ml
    • 8.2.2. 250 To 500 Ml
    • 8.2.3. 50 To 100 Ml
    • 8.2.4. Above 500 Ml
  • 8.3. Ready-To-Use

9. Infusion Bags Market, by Application

  • 9.1. Blood Transfusion
  • 9.2. Chemotherapy
  • 9.3. Hydration Therapy
  • 9.4. Parenteral Nutrition

10. Infusion Bags Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Home Healthcare
  • 10.4. Hospitals

11. Infusion Bags Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Hospital Pharmacies
  • 11.3. Online Pharmacies
  • 11.4. Retail Pharmacies

12. Infusion Bags Market, by Material

  • 12.1. Ethylene Vinyl Acetate
  • 12.2. Polyolefin
  • 12.3. Pvc

13. Infusion Bags Market, by Capacity

  • 13.1. 100 To 250 Ml
  • 13.2. 250 To 500 Ml
  • 13.3. 50 To 100 Ml
  • 13.4. Above 500 Ml

14. Infusion Bags Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Infusion Bags Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Infusion Bags Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Baxter International Inc.
    • 17.3.2. B. Braun Melsungen AG
    • 17.3.3. Fresenius Kabi AG
    • 17.3.4. Terumo Corporation
    • 17.3.5. Becton, Dickinson and Company
    • 17.3.6. Pfizer Inc.
    • 17.3.7. ICU Medical, Inc.
    • 17.3.8. Nipro Corporation
    • 17.3.9. Smiths Group plc
    • 17.3.10. Hospira, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INFUSION BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INFUSION BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INFUSION BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INFUSION BAGS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INFUSION BAGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INFUSION BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INFUSION BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INFUSION BAGS MARKET SIZE, BY CAPACITY, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL INFUSION BAGS MARKET SIZE, BY CAPACITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INFUSION BAGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS INFUSION BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL INFUSION BAGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL INFUSION BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. INFUSION BAGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. INFUSION BAGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INFUSION BAGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INFUSION BAGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INFUSION BAGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INFUSION BAGS MARKET SIZE, BY ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INFUSION BAGS MARKET SIZE, BY ADDITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INFUSION BAGS MARKET SIZE, BY ADDITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INFUSION BAGS MARKET SIZE, BY ADDITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INFUSION BAGS MARKET SIZE, BY ADDITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INFUSION BAGS MARKET SIZE, BY ADDITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INFUSION BAGS MARKET SIZE, BY READY-TO-USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INFUSION BAGS MARKET SIZE, BY READY-TO-USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INFUSION BAGS MARKET SIZE, BY READY-TO-USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INFUSION BAGS MARKET SIZE, BY READY-TO-USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INFUSION BAGS MARKET SIZE, BY READY-TO-USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INFUSION BAGS MARKET SIZE, BY READY-TO-USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INFUSION BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INFUSION BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INFUSION BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INFUSION BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INFUSION BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INFUSION BAGS MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INFUSION BAGS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INFUSION BAGS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INFUSION BAGS MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INFUSION BAGS MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INFUSION BAGS MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INFUSION BAGS MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INFUSION BAGS MARKET SIZE, BY HYDRATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INFUSION BAGS MARKET SIZE, BY HYDRATION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INFUSION BAGS MARKET SIZE, BY HYDRATION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INFUSION BAGS MARKET SIZE, BY HYDRATION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INFUSION BAGS MARKET SIZE, BY HYDRATION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INFUSION BAGS MARKET SIZE, BY HYDRATION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INFUSION BAGS MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INFUSION BAGS MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INFUSION BAGS MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INFUSION BAGS MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INFUSION BAGS MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INFUSION BAGS MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INFUSION BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INFUSION BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INFUSION BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INFUSION BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INFUSION BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INFUSION BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INFUSION BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INFUSION BAGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INFUSION BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INFUSION BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INFUSION BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INFUSION BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INFUSION BAGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INFUSION BAGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INFUSION BAGS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INFUSION BAGS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INFUSION BAGS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INFUSION BAGS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INFUSION BAGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INFUSION BAGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INFUSION BAGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INFUSION BAGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INFUSION BAGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INFUSION BAGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INFUSION BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INFUSION BAGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INFUSION BAGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INFUSION BAGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INFUSION BAGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INFUSION BAGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INFUSION BAGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INFUSION BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INFUSION BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INFUSION BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INFUSION BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INFUSION BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INFUSION BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INFUSION BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INFUSION BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INFUSION BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INFUSION BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INFUSION BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INFUSION BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INFUSION BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INFUSION BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INFUSION BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INFUSION BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INFUSION BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INFUSION BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INFUSION BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INFUSION BAGS MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INFUSION BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INFUSION BAGS MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INFUSION BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INFUSION BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INFUSION BAGS MARKET SIZE, BY 100 TO 250 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INFUSION BAGS MARKET SIZE, BY 250 TO 500 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INFUSION BAGS MARKET SIZE, BY 50 TO 100 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INFUSION BAGS MARKET SIZE, BY ABOVE 500 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INFUSION BAGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INFUSION BAGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS INFUSION BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS INFUSION BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL INFUSION BAGS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL INFUSION BAGS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 323. GCC INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. GCC INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. GCC INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. GCC INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. GCC INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 328. GCC INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 329. GCC INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. GCC INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. GCC INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. GCC INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. GCC INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 334. GCC INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 335. GCC INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 336. GCC INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 337. GCC INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 338. GCC INFUSION BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 341. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 342. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 343. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2018-2024 (USD MILLION)
  • TABLE 344. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY LARGE VOLUME, 2025-2032 (USD MILLION)
  • TABLE 345. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 346. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 347. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 348. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 349. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 350. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 351. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 352. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 353. EUROPEAN UNION INFUSION BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 354. EUROPEAN UNION INFUSI